Zhiqi Feng

Statistics

Publications

Citations

244

H-Index

Active since

2019

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Guangxi Normal University

Zhiqi Feng is an author at State Key Laboratory of Natural Medicine specializing in pharmacology, peroxisome proliferator-activated receptors, and medicinal chemistry.

ORCID

Publications per year

2019–2025

Publications

Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors

Enqin Li, Wei Zhao, Chenxi Zhang et al. · European Journal of Pharmaceutical Sciences · 2019 · 63 citations

Medicine, Oncology, Pharmacology +13

Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression

Caiping Chen, Kun Chen, Zhiqi Feng et al. · Acta Pharmaceutica Sinica B · 2019 · 41 citations · Full text

Medicine, Oncology, Pharmacology +14

Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis

Zhiqi Feng, Jiehao Xiang, Hui Liu et al. · Journal of Medicinal Chemistry · 2022 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation

Xi Han, Guangcai Ma, Rui-Kun Peng et al. · Journal of Medicinal Chemistry · 2025 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Blockchain-oriented approach for detecting cyber-attack transactions

Zhiqi Feng, Yongli Li, Xiaochen Ma · Financial Innovation · 2023 · 20 citations · Full text

Computing, Computer Science, Cybersecurity +13

1–5 of 10